AU1594801A - Liquid heparin formulation - Google Patents

Liquid heparin formulation

Info

Publication number
AU1594801A
AU1594801A AU15948/01A AU1594801A AU1594801A AU 1594801 A AU1594801 A AU 1594801A AU 15948/01 A AU15948/01 A AU 15948/01A AU 1594801 A AU1594801 A AU 1594801A AU 1594801 A AU1594801 A AU 1594801A
Authority
AU
Australia
Prior art keywords
heparin formulation
liquid heparin
liquid
formulation
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15948/01A
Inventor
Rajesh Agarwal
Kiran Chaudhary
George F. Klein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emisphere Technologies Inc
Original Assignee
Emisphere Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Technologies Inc filed Critical Emisphere Technologies Inc
Publication of AU1594801A publication Critical patent/AU1594801A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
AU15948/01A 1999-11-12 2000-11-10 Liquid heparin formulation Abandoned AU1594801A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16520999P 1999-11-12 1999-11-12
US60165209 1999-11-12
PCT/US2000/030890 WO2001034114A1 (en) 1999-11-12 2000-11-10 Liquid heparin formulation

Publications (1)

Publication Number Publication Date
AU1594801A true AU1594801A (en) 2001-06-06

Family

ID=22597926

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15948/01A Abandoned AU1594801A (en) 1999-11-12 2000-11-10 Liquid heparin formulation

Country Status (4)

Country Link
AU (1) AU1594801A (en)
DE (1) DE20022960U1 (en)
MX (1) MXPA02004741A (en)
WO (1) WO2001034114A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
ITMI20012599A1 (en) 2001-12-11 2003-06-11 Cosmo Spa PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HEPARINE OR DERIVATIVES, USEFUL FOR THERAPY OF INFLAMMATORY DISEASES OF THE INT
AU2005240206B2 (en) 2004-05-06 2011-04-07 Emisphere Technologies, Inc. Solid dosage form of wetted heparin
CA2565188C (en) 2004-05-14 2014-03-04 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
MXPA06013295A (en) 2004-05-19 2007-02-22 Emisphere Tech Inc Acyclovir formulations.
NZ588373A (en) 2004-05-19 2012-01-12 Emisphere Tech Inc Topical cromolyn formulations
CN101014360A (en) 2004-08-03 2007-08-08 埃米斯菲尔技术公司 Antidiabetic oral insulin-biguanide combination
AU2005321803B2 (en) 2004-12-29 2012-02-09 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2007011958A2 (en) 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
ATE552004T1 (en) 2005-11-30 2012-04-15 Istituto G Ronzoni ORAL HEPARINE DERIVATIVES
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2007133944A2 (en) 2006-05-09 2007-11-22 Emisphere Technologies, Inc. Topical administration of acyclovir
EP2040718B1 (en) 2006-06-28 2017-12-27 Emisphere Technologies, Inc. Gallium nitrate formulations
PL3050568T3 (en) 2007-03-13 2021-06-14 Jds Therapeutics, Llc Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
MX344925B (en) 2011-03-01 2017-01-11 N21 Acquisition Holding Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders.
WO2017127025A1 (en) * 2016-01-19 2017-07-27 Namz Pte. Ltd. A cosmetic composition and the use thereof for regulating skin quality
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (en) * 1990-06-26 1994-03-18 Rhone Poulenc Sante LOW MOLECULAR WEIGHT POLYSACCHARIDE BLENDS PROCESS FOR PREPARATION AND USE.
US5650386A (en) * 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2001034114A1 (en) 2001-05-17
MXPA02004741A (en) 2003-12-11
DE20022960U1 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU8745698A (en) Liquid dispenser
AU1594801A (en) Liquid heparin formulation
AU3005600A (en) Liquid dispenser
AU2919001A (en) Syringe
AU4340900A (en) Devices
AU4328800A (en) Pharmaceutical formulation
GB9817354D0 (en) Liquid formulation
AU5754100A (en) Liquid herbicide composition
AU7411100A (en) Liquid bread improving composition
AU2021901A (en) Fluid level monitor
AU6062700A (en) Devices
AU1554301A (en) Radioprotecting agent
AU3303300A (en) Cleaning formulation
AU1533601A (en) Hollow-needle devices
AU6164800A (en) Level sensor-switch
AU4584600A (en) Liquid container
AU3977500A (en) Liquid cleaning arrangement
AU3839900A (en) Pharmaceutical formulation
AU2002222581A1 (en) Liquid coater
AU1388501A (en) Pharmaceutical formulation
AU5182099A (en) Pharmaceutical formulation
AU6062600A (en) Devices
PL345768A1 (en) Liquid formulation
AU3133400A (en) Syringe
AU1649700A (en) Novel formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase